Company record

BigHat Biosciences

Updated September 26, 2026 · Presspool

BigHat Biosciences designs protein therapeutics with a platform that pairs AI models with autonomous, high-throughput lab experiments. bighatbio.com

Funding

Latest announced financing: $75 million, Series C, led by DFJ Growth and Premji Invest, announced September 24, 2026.

• Listed in the AI startup funding roster for September 21–26, 2026.

Whether AI names BigHat Biosciences

• Machine Relations Index: Not cited in any Machine Relations Index answer, May 10, 2026 to September 25, 2026.

A company counts when an AI answer names it or cites its website. Answers vary from run to run, so each count is a dated sample.

Sources

• BigHat Biosciences
• BiopharmaTrend

Every fact on this page links its source. Corrections need a public source: see Contact.